CME Presentations

Decoding GLP-1 Receptor Agonists and Simplifying Diabetes Care: An Individualized Educational Journey for Interprofessional Clinicians and Their Patients


Presentations


Speakers


CME Information

Decoding GLP-1 Receptor Agonists and Simplifying Diabetes Care: An Individualized Educational Journey for Interprofessional Clinicians and Their Patients


PIM Logo PQH Logo

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to:
  • Individualize GLP-1 RA selection based on patient presentation and preference, including needs for glucose reduction, cardiovascular risk, weight, administration route, and frequency (Modules 1, 2, 3 & 5)
  • Review data related to an improved understanding of the impact of GLP-1 RAs on kidney health and other microvascular outcomes (Modules 4 & 5)
  • Implement the 2021 ADA standard of care pertaining to the use of GLP-1 RAs for reduction of hyperglycemia in people with T2DM (Modules 1 & 5)
  • Enhance patient understanding of the rationale for selecting a GLP-1-receptor agonist as part of diabetes treatment and share strategies to manage adverse events Modules 1, 2, 3, 4 & 5)
  • Describe strategies to enhance access to diabetes care among underserved, high-risk populations, such as African American patients and those in rural or disadvantaged areas (Module 6)
Jointly provided by Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC (PQHE)

This activity is supported by an educational grant from Novo Nordisk, Inc.

TUITION

Complimentary

JointlyAccreditedProvider Logo

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

LIVE CREDIT DESIGNATION STATEMENTS

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 3.0 contact hours.

ENDURING CREDIT DESIGNATION STATEMENTS

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 3.0 contact hours.

DATE OF RELEASE/EXPIRATION

Live Activity

Monday, August 30, 2021, from 10:00am – 11:00am ET
  • 10:00am – 10:30am ET: Putting it All Together for GLP-1 Targeted Agents: One Size Does Not Fit All
  • 10:30 – 11:00am ET: Diabetes and Underserved Populations: Emergency Calling for Immediate Action

Enduring Material

The enduring material will be available from August 16, 2021 to August 30, 2022
  • Monday, August 16, 2021
  • Guidelines and Their Rationale: A 2021 Refresher
  • GLP-1 and Glucose Regulation
  • Magnifying Glass on the CV Properties of GLP-1 RAs
  • Magnifying Glass on the Renal Impacts of GLP-1 RA: Current and Future
  • Monday, August 30, 2021
  • Putting it All Together for GLP-1 Targeted Agents: One Size Does Not Fit All
  • Diabetes and Underserved Populations: Emergency Calling for Immediate Action

TARGET AUDIENCE

This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes.

ESTIMATED TIME TO COMPLETE

This activity consists of 6 modules which should take approximately 3 hours to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.DiabetesSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Jay H. Shubrook, DO
Professor
Diabetologist
Touro University California
Consulting Fees: Astra Zeneca, Bayer, Novo Nordisk
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Cleveland Clinic Diabetes Center
Consulting Fees: Speaker – Abbott, Dexcom, Insulet, Medtronic, Novo Nordisk; Advisory Board – Lilly
Nicolas Cuttriss, MD, MPH, FAAP
Pediatric Endocrinologist
ENDO Diabetes & Wellness
Founding Director ECHO Diabetes Action Network
Consulting Fees: The Leona M. and Harry B. Helmsley Charitable Trust; Cecelia Health
Other: Chairman of the Board, AYUDA

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Carole Drexel
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planners, Alissa Yost and Patricia Gellasch, PhD, APN-C, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact DiabetesSeriesLive at 877-394-1306 or at Support@DiabetesSeriesLive.com.